[
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[Mountain Lake Acquisition Corp. II] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/2094265/000121390026010358/0001213900-26-010358-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_Mountain Lake Acquisition Corp. II_AGREEMENT_2026-01-31",
    "details": {
      "company": "Mountain Lake Acquisition Corp. II",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0001213900-26-010358 <b>Size:</b> 1 MB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n<br>Item 3.02: Unregistered Sales of Equity Securities\n<br>Ite"
    }
  },
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[Aspira Women's Health Inc.] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/926617/000092661726000007/0000926617-26-000007-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_Aspira Women's Health Inc._AGREEMENT_2026-01-31",
    "details": {
      "company": "Aspira Women's Health Inc.",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0000926617-26-000007 <b>Size:</b> 555 KB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n<br>Item 2.03: Creation of a Direct Financial Obligation or "
    }
  },
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[NN INC] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/918541/000110465926008723/0001104659-26-008723-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_NN INC_AGREEMENT_2026-01-31",
    "details": {
      "company": "NN INC",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0001104659-26-008723 <b>Size:</b> 247 KB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n<br>Item 2.03: Creation of a Direct Financial Obligation or "
    }
  },
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[SARATOGA INVESTMENT CORP.] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/1377936/000121390026010305/0001213900-26-010305-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_SARATOGA INVESTMENT CORP._AGREEMENT_2026-01-31",
    "details": {
      "company": "SARATOGA INVESTMENT CORP.",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0001213900-26-010305 <b>Size:</b> 490 KB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n<br>Item 2.03: Creation of a Direct Financial Obligation or "
    }
  },
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[Aspire Biopharma Holdings, Inc.] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/1847345/000149315226004543/0001493152-26-004543-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_Aspire Biopharma Holdings, Inc._AGREEMENT_2026-01-31",
    "details": {
      "company": "Aspire Biopharma Holdings, Inc.",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0001493152-26-004543 <b>Size:</b> 666 KB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n<br>Item 3.02: Unregistered Sales of Equity Securities\n<br>I"
    }
  },
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[ASP Isotopes Inc.] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/1921865/000147793226000555/0001477932-26-000555-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_ASP Isotopes Inc._AGREEMENT_2026-01-31",
    "details": {
      "company": "ASP Isotopes Inc.",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0001477932-26-000555 <b>Size:</b> 157 KB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n"
    }
  },
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[MADRIGAL PHARMACEUTICALS, INC.] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/1157601/000110465926008698/0001104659-26-008698-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_MADRIGAL PHARMACEUTICALS, INC._AGREEMENT_2026-01-31",
    "details": {
      "company": "MADRIGAL PHARMACEUTICALS, INC.",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0001104659-26-008698 <b>Size:</b> 227 KB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n<br>Item 9.01: Financial Statements and Exhibits\n"
    }
  },
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[Comstock Inc.] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/1120970/000121390026010287/0001213900-26-010287-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_Comstock Inc._AGREEMENT_2026-01-31",
    "details": {
      "company": "Comstock Inc.",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0001213900-26-010287 <b>Size:</b> 877 KB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n<br>Item 3.02: Unregistered Sales of Equity Securities\n<br>I"
    }
  },
  {
    "fact_type": "CORPORATE_ACTION",
    "fact_text": "[PENNANTPARK INVESTMENT CORP] 주요 계약 체결 (Material Agreement)",
    "source": "SEC 8-K (Official)",
    "source_ref": "https://www.sec.gov/Archives/edgar/data/1383414/000119312526031964/0001193125-26-031964-index.htm",
    "source_date": "2026-01-30",
    "evidence_grade": "HARD_FACT",
    "reliability_score": 95,
    "independence_key": "CORP_PENNANTPARK INVESTMENT CORP_AGREEMENT_2026-01-31",
    "details": {
      "company": "PENNANTPARK INVESTMENT CORP",
      "action_type": "AGREEMENT",
      "raw_summary": "\n <b>Filed:</b> 2026-01-30 <b>AccNo:</b> 0001193125-26-031964 <b>Size:</b> 815 KB\n<br>Item 1.01: Entry into a Material Definitive Agreement\n<br>Item 2.03: Creation of a Direct Financial Obligation or "
    }
  }
]